Association Between Inflammatory Bowel Disease and Viral Infections

被引：0
作者：
Tannaz Dehghani
Omid Gholizadeh
Maziar Daneshvar
Mohammad Mahdi Nemati
Sama Akbarzadeh
Parya Amini
Hamed Afkhami
Maryam Kohansal
Zahra Javanmard
Vahdat Poortahmasebi
机构：
[1] Lorestan University of Medical Sciences,Internal Medicine
[2] Tabriz University of Medical Sciences,Department of Bacteriology and Virology, Faculty of Medicine
[3] Tehran University of Medical Sciences,Research Center for Clinical Virology
[4] Tehran University of Medical Sciences,Department of Animal Biology, Faculty of Natural Science
[5] University of Tabriz,Faculty of Medicine
[6] Yasouj University of Medical Sciences,Department of Medical Microbiology, Faculty of Medicine
[7] Shahed University of Medical Science,Department of Medical Microbiology, Faculty of Medicine
[8] Noncommunicable Diseases Research Center,undefined
[9] Fasa University of Medical Sciences,undefined
[10] Tehran University of Medical Sciences,undefined
来源：
Current Microbiology | 2023年 / 80卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Chronic inflammatory gastrointestinal diseases such as Crohn's disease (CD) and ulcerative colitis (UC) are known as inflammatory bowel disorders (IBD). Patients with inflammatory bowel illnesses are more susceptible to viral infections. In people with IBD, viral infections have emerged as a significant issue. Viral infections are often difficult to identify and have a high morbidity and fatality rate. We reviewed studies on viral infections and IBD, concentrating on Cytomegalovirus (CMV), SARS-CoV-2, Epstein-Barr virus (EBV), enteric viruses, and hepatitis B virus (HBV). Also, the effect of IBD on these viral infections is discussed. These data suggest that patients with IBD are more likely to get viral infections. As a result, practitioners should be aware of the increased risk of viral infections in inflammatory bowel disease patients.
引用
收藏
相关论文
共 110 条
[1]  
Vernon-Roberts A(2020)Validation of a revised knowledge assessment tool for children with inflammatory bowel disease (IBD-KID2) Inflamm Intest Dis 5 70-77
[2]  
Wong DJ(2019)Surgery in the age of biologics Gastroenterol Rep 7 77-90
[3]  
Kmieć Z(2017)Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease Adv Med Sci 62 1-16
[4]  
Cyman M(2023)Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study Expert Opin Biol Ther 18 14-23
[5]  
Ślebioda TJ(2020)Ulcerative colitis and Crohn’s disease have similar burden and goals for treatment Clin Gastroenterol Hepatol 7 1-15
[6]  
Mocci G(2021)Pain management in inflammatory bowel disease: feasibility of an online therapist-supported CBT-based self-management intervention Pilot Feasibility Stud 30 408-535.e6
[7]  
Le Berre C(2017)Interactions between Intestinal Microbiota and Host Immune Response in inflammatory bowel disease Front Immunol 161 522-507
[8]  
Sweeney L(2019)Immunoglobulin G4-related immune responses to common food antigens in patients with ulcerative colitis and Crohn’s disease Turk J Gastroenterol 50 495-1652
[9]  
Zhang M(2021)Human microbiota flagellins drive adaptive immune responses in Crohn’s disease Gastroenterology 27 1641-5
[10]  
Lee HS(2015)The microbiota in inflammatory bowel disease J Gastroenterol 335 1-608.e10
12345678910